Immunocore Holdings plc (NASDAQ:IMCR) is a promising small cap stock with strong potential growth. Analysts have given mixed ratings, highlighting the company's innovative TCR therapeutics and lead product KIMMTRAK for melanoma treatment.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing